Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Primary Biliary Cirrhosis Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Primary Biliary Cirrhosis Drug market. Detailed analysis of key players, along with key growth strategies adopted by Primary Biliary Cirrhosis Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
NGM Biopharmaceuticals, Inc
CymaBay Therapeutics, Inc
MediGene AG
Dr Falk Pharma GmbH
Intercept Pharmaceuticals, Inc
Enanta Pharmaceuticals, Inc
AlbireoPharma
GlaxoSmithKline Plc
Virobay Inc
Johnson & Johnson
By Type:
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
By End-User:
Clinic
Hospital
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Primary Biliary Cirrhosis Drug Market
-
1.3 Market Segment by Type
-
1.3.1 USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Budesonide from 2016 to 2027
-
1.3.2 USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of FFP-104 from 2016 to 2027
-
1.3.3 USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of GSK-2330672 from 2016 to 2027
-
1.3.4 USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of MBX-8025 from 2016 to 2027
-
1.3.5 USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of NGM-282 from 2016 to 2027
-
1.3.6 USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.2 USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.3 USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Primary Biliary Cirrhosis Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Primary Biliary Cirrhosis Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Budesonide
-
3.4.2 Market Size and Growth Rate of FFP-104
-
3.4.3 Market Size and Growth Rate of GSK-2330672
-
3.4.4 Market Size and Growth Rate of MBX-8025
-
3.4.5 Market Size and Growth Rate of NGM-282
-
3.4.6 Market Size and Growth Rate of Others
4 Segmentation of Primary Biliary Cirrhosis Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Primary Biliary Cirrhosis Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Primary Biliary Cirrhosis Drug in Clinic
-
4.4.2 Market Size and Growth Rate of Primary Biliary Cirrhosis Drug in Hospital
-
4.4.3 Market Size and Growth Rate of Primary Biliary Cirrhosis Drug in Others
5 Market Analysis by Regions
-
5.1 USA Primary Biliary Cirrhosis Drug Production Analysis by Regions
-
5.2 USA Primary Biliary Cirrhosis Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Primary Biliary Cirrhosis Drug Landscape Analysis
-
6.1 West USA Primary Biliary Cirrhosis Drug Landscape Analysis by Major Types
-
6.2 West USA Primary Biliary Cirrhosis Drug Landscape Analysis by Major End-Users
7 South USA Primary Biliary Cirrhosis Drug Landscape Analysis
-
7.1 South USA Primary Biliary Cirrhosis Drug Landscape Analysis by Major Types
-
7.2 South USA Primary Biliary Cirrhosis Drug Landscape Analysis by Major End-Users
8 Middle West USA Primary Biliary Cirrhosis Drug Landscape Analysis
-
8.1 Middle West USA Primary Biliary Cirrhosis Drug Landscape Analysis by Major Types
-
8.2 Middle West USA Primary Biliary Cirrhosis Drug Landscape Analysis by Major End-Users
9 Northeast USA Primary Biliary Cirrhosis Drug Landscape Analysis
-
9.1 Northeast USA Primary Biliary Cirrhosis Drug Landscape Analysis by Major Types
-
9.2 Northeast USA Primary Biliary Cirrhosis Drug Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 NGM Biopharmaceuticals, Inc
-
10.1.1 NGM Biopharmaceuticals, Inc Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 CymaBay Therapeutics, Inc
-
10.2.1 CymaBay Therapeutics, Inc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 MediGene AG
-
10.3.1 MediGene AG Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Dr Falk Pharma GmbH
-
10.4.1 Dr Falk Pharma GmbH Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Intercept Pharmaceuticals, Inc
-
10.5.1 Intercept Pharmaceuticals, Inc Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Enanta Pharmaceuticals, Inc
-
10.6.1 Enanta Pharmaceuticals, Inc Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 AlbireoPharma
-
10.7.1 AlbireoPharma Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 GlaxoSmithKline Plc
-
10.8.1 GlaxoSmithKline Plc Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Virobay Inc
-
10.9.1 Virobay Inc Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Johnson & Johnson
-
10.10.1 Johnson & Johnson Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Budesonide from 2016 to 2027
-
Figure USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of FFP-104 from 2016 to 2027
-
Figure USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of GSK-2330672 from 2016 to 2027
-
Figure USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of MBX-8025 from 2016 to 2027
-
Figure USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of NGM-282 from 2016 to 2027
-
Figure USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Primary Biliary Cirrhosis Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Primary Biliary Cirrhosis Drug
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Primary Biliary Cirrhosis Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Primary Biliary Cirrhosis Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Budesonide
-
Figure Market Size and Growth Rate of FFP-104
-
Figure Market Size and Growth Rate of GSK-2330672
-
Figure Market Size and Growth Rate of MBX-8025
-
Figure Market Size and Growth Rate of NGM-282
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Primary Biliary Cirrhosis Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Primary Biliary Cirrhosis Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Others
-
Table USA Primary Biliary Cirrhosis Drug Production by Regions
-
Table USA Primary Biliary Cirrhosis Drug Production Share by Regions
-
Figure USA Primary Biliary Cirrhosis Drug Production Share by Regions in 2016
-
Figure USA Primary Biliary Cirrhosis Drug Production Share by Regions in 2021
-
Figure USA Primary Biliary Cirrhosis Drug Production Share by Regions in 2027
-
Table USA Primary Biliary Cirrhosis Drug Consumption by Regions
-
Table USA Primary Biliary Cirrhosis Drug Consumption Share by Regions
-
Figure USA Primary Biliary Cirrhosis Drug Consumption Share by Regions in 2016
-
Figure USA Primary Biliary Cirrhosis Drug Consumption Share by Regions in 2021
-
Figure USA Primary Biliary Cirrhosis Drug Consumption Share by Regions in 2027
-
Table West USA Primary Biliary Cirrhosis Drug Consumption by Types from 2016 to 2027
-
Table West USA Primary Biliary Cirrhosis Drug Consumption Share by Types from 2016 to 2027
-
Figure West USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2016
-
Figure West USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2021
-
Figure West USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2027
-
Table West USA Primary Biliary Cirrhosis Drug Consumption by End-Users from 2016 to 2027
-
Table West USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2016
-
Figure West USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2021
-
Figure West USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2027
-
Table South USA Primary Biliary Cirrhosis Drug Consumption by Types from 2016 to 2027
-
Table South USA Primary Biliary Cirrhosis Drug Consumption Share by Types from 2016 to 2027
-
Figure South USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2016
-
Figure South USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2021
-
Figure South USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2027
-
Table South USA Primary Biliary Cirrhosis Drug Consumption by End-Users from 2016 to 2027
-
Table South USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2016
-
Figure South USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2021
-
Figure South USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2027
-
Table Middle West USA Primary Biliary Cirrhosis Drug Consumption by Types from 2016 to 2027
-
Table Middle West USA Primary Biliary Cirrhosis Drug Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2016
-
Figure Middle West USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2021
-
Figure Middle West USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2027
-
Table Middle West USA Primary Biliary Cirrhosis Drug Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2016
-
Figure Middle West USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2021
-
Figure Middle West USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2027
-
Table Northeast USA Primary Biliary Cirrhosis Drug Consumption by Types from 2016 to 2027
-
Table Northeast USA Primary Biliary Cirrhosis Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2016
-
Figure Northeast USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2021
-
Figure Northeast USA Primary Biliary Cirrhosis Drug Consumption Share by Types in 2027
-
Table Northeast USA Primary Biliary Cirrhosis Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2016
-
Figure Northeast USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2021
-
Figure Northeast USA Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of NGM Biopharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NGM Biopharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of NGM Biopharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of NGM Biopharmaceuticals, Inc
-
Table Product and Service Introduction of NGM Biopharmaceuticals, Inc
-
Table Company Profile and Development Status of CymaBay Therapeutics, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CymaBay Therapeutics, Inc
-
Figure Sales and Growth Rate Analysis of CymaBay Therapeutics, Inc
-
Figure Revenue and Market Share Analysis of CymaBay Therapeutics, Inc
-
Table Product and Service Introduction of CymaBay Therapeutics, Inc
-
Table Company Profile and Development Status of MediGene AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MediGene AG
-
Figure Sales and Growth Rate Analysis of MediGene AG
-
Figure Revenue and Market Share Analysis of MediGene AG
-
Table Product and Service Introduction of MediGene AG
-
Table Company Profile and Development Status of Dr Falk Pharma GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Falk Pharma GmbH
-
Figure Sales and Growth Rate Analysis of Dr Falk Pharma GmbH
-
Figure Revenue and Market Share Analysis of Dr Falk Pharma GmbH
-
Table Product and Service Introduction of Dr Falk Pharma GmbH
-
Table Company Profile and Development Status of Intercept Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intercept Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of Intercept Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of Intercept Pharmaceuticals, Inc
-
Table Product and Service Introduction of Intercept Pharmaceuticals, Inc
-
Table Company Profile and Development Status of Enanta Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enanta Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of Enanta Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of Enanta Pharmaceuticals, Inc
-
Table Product and Service Introduction of Enanta Pharmaceuticals, Inc
-
Table Company Profile and Development Status of AlbireoPharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AlbireoPharma
-
Figure Sales and Growth Rate Analysis of AlbireoPharma
-
Figure Revenue and Market Share Analysis of AlbireoPharma
-
Table Product and Service Introduction of AlbireoPharma
-
Table Company Profile and Development Status of GlaxoSmithKline Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc
-
Table Product and Service Introduction of GlaxoSmithKline Plc
-
Table Company Profile and Development Status of Virobay Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Virobay Inc
-
Figure Sales and Growth Rate Analysis of Virobay Inc
-
Figure Revenue and Market Share Analysis of Virobay Inc
-
Table Product and Service Introduction of Virobay Inc
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
